Frazier Life Sciences Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320M | Sell |
3,383,950
-73,900
|
|
||||
|
2025
Q1 | $220M | Buy |
3,457,850
+73,900
|
|
||||
|
2024
Q4 | $157M | Hold |
3,383,950
|
|
||||
|
2024
Q3 | $97.4M | Buy |
3,383,950
+69,601
|
|
||||
|
2024
Q2 | $47.9M | Buy |
3,314,349
+300,000
|
|
||||
|
2024
Q1 | $48.5M | Hold |
3,014,349
|
|
||||
|
2023
Q4 | $59.9M | Hold |
3,014,349
|
|
||||
|
2023
Q3 | $49.1M | Buy |
3,014,349
+70,000
|
|
||||
|
2023
Q2 | $62.2M | Hold |
2,944,349
|
|
||||
|
2023
Q1 | $59.1M | Buy |
2,944,349
+128,629
|
|
||||
|
2022
Q4 | $73.6M | Buy |
2,815,720
+716,179
|
|
||||
|
2022
Q3 | $21.5M | Buy |
+2,099,541
|
|